(Q44214622)

30 November 2017

title

Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema (English)

1 reference

30 November 2017

1 reference

1 reference

3

Sundaram Natarajan

1 reference

30 November 2017

Saumil Sheth

1

1 reference

30 November 2017

Ryan Rush

series ordinal

2

1 reference

30 November 2017

Mark Gillies

series ordinal

4

1 reference

30 November 2017

publication date

24 March 2011

1 reference

Clinical and Experimental Ophthalmology

30 November 2017

published in

1 reference

30 November 2017

volume

39

1 reference

30 November 2017

issue

7

1 reference

30 November 2017

page(s)

673-681

1 reference

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Optical coherence tomographic patterns of diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Intravitreal dexamethasone for diabetic macular edema: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

A standardized method for reporting changes in macular thickening using optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2011.02504.X

10.1111/J.1442-9071.2011.02504.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference